Tag: Pfizer
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford…
Read More
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full strength does were applied, which was 62% effective,…
Read More
Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis
Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is a better efficacy rate than Pfizer reported previously, when it announced a…
Read More
Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine
Pharma giant Pfizer announced on Tuesday that it’s working on a potential COVID-19 vaccine with BioNTech, a German company working on new kinds of immunotherapy treatments. The joint effort, confirmed Tuesday via a signed letter of intent, will see both partners work together on a messenger RNA-based vaccine that will…
Read More